B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Arthritis drug tested to tame Life-Threatening CAR-T side effects
Disease control CompletedThis study tested if a drug called anakinra could prevent two serious and potentially life-threatening side effects—cytokine release syndrome (CRS) and neurotoxicity—in patients with B-cell lymphoma receiving CAR-T cell therapy. Twenty-seven adult patients received anakinra along…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for kids with aggressive blood cancers: adding a targeted drug to standard chemo
Disease control CompletedThis trial tested whether adding a targeted drug called rituximab to standard chemotherapy could improve survival for children and adolescents with high-risk B-cell lymphoma or leukemia. It involved 482 young patients aged 6 months to 18 years with advanced disease. The main goal…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC